- TheStreet.com•10 minutes ago
Pfizer will showcase third-quarter results, but investors will be more focused on the potential for its Inflectra drug, as well as its outlook on M&A.
- Market Realist•1 hour ago
On September 28, 2016, Pfizer (PFE) announced the completion of its acquisition of Medivation for around $14 billion.
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||32.01 x 13400|
|Ask||32.02 x 4400|
|Day's Range||31.99 - 32.56|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||28.45|
|Avg Vol (3m)||19,193,012|
|Dividend & Yield||1.20 (3.70%)|